Cite
HARVARD Citation
Mickevicius, T. et al. (2023). Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Management. Cornea. 42 (4), pp. 507-519. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mickevicius, T. et al. (2023). Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Management. Cornea. 42 (4), pp. 507-519. [Online].